- cafead Apr 21, 2024 at 10:42: PM
via The market expects Bristol Myers Squibb (BMY) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
article source
article source